Cathay Biotech Stock Return On Equity
| 688065 Stock | 45.20 0.30 0.67% |
Cathay Biotech fundamentals help investors to digest information that contributes to Cathay Biotech's financial success or failures. It also enables traders to predict the movement of Cathay Stock. The fundamental analysis module provides a way to measure Cathay Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cathay Biotech stock.
Cathay | Return On Equity |
Cathay Biotech Company Return On Equity Analysis
Cathay Biotech's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Cathay Biotech Return On Equity | 0.026 |
Most of Cathay Biotech's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cathay Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Cathay Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Cathay Biotech has a Return On Equity of 0.026. This is 97.14% lower than that of the Chemicals sector and 99.66% lower than that of the Materials industry. The return on equity for all China stocks is 108.39% lower than that of the firm.
Cathay Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cathay Biotech's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cathay Biotech could also be used in its relative valuation, which is a method of valuing Cathay Biotech by comparing valuation metrics of similar companies.Cathay Biotech is currently under evaluation in return on equity category among its peers.
Cathay Fundamentals
| Return On Equity | 0.026 | |||
| Return On Asset | 0.0106 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 22.8 B | |||
| Shares Outstanding | 583.38 M | |||
| Shares Owned By Insiders | 61.34 % | |||
| Shares Owned By Institutions | 11.09 % | |||
| Price To Book | 2.32 X | |||
| Price To Sales | 9.58 X | |||
| Revenue | 2.11 B | |||
| Gross Profit | 2.44 B | |||
| EBITDA | 608.83 M | |||
| Net Income | 366.52 M | |||
| Total Debt | 1.53 B | |||
| Book Value Per Share | 19.74 X | |||
| Cash Flow From Operations | 569.45 M | |||
| Earnings Per Share | 0.68 X | |||
| Target Price | 69.35 | |||
| Number Of Employees | 1.8 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 26.47 B | |||
| Total Asset | 18.83 B | |||
| Retained Earnings | 2.07 B | |||
| Working Capital | 4.16 B | |||
| Annual Yield | 0 % | |||
| Net Asset | 18.83 B | |||
| Last Dividend Paid | 0.19 |
About Cathay Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cathay Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cathay Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cathay Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.